INSULIN PUMP PROVISION

That this House welcomes the Medical Technology Group's Pump Action campaign to improve access to insulin pump therapy for everyone with type 1 diabetes in the UK who would benefit; notes the findings of a Freedom of Information survey of primary care trusts in which the average rate of pump provision for people with type 1 diabetes is shown to be 3.9 per cent. compared to the 12 per cent. benchmark recommended by the National Institute for Health and Clinical Excellence; is concerned that potentially tens of thousands of eligible patients are missing out on pump therapy as an alternative to multiple daily injections; acknowledges that pump therapy improves patient outcomes through better management of blood glucose levels, and a reduced risk of complications while bringing short and long-term economic benefits to the NHS by reducing both planned and emergency hospital admissions; and calls on the Government to work with the Medical Technology Group and other stakeholders to implement the recommendations contained within Pump Action, and ensure that local commissioners, provider trusts and emerging general practitioner consortia utilise the NHS Technology Adoption Centre's How to Why to Guide on insulin pumps to ensure that all eligible patients can access insulin pumps as soon as possible.